Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
about
Overexpression of pyruvate dehydrogenase kinase 1 in retinoblastoma: A potential therapeutic opportunity for targeting vitreous seeds and hypoxic regions.Melanocytic nevi and melanoma: unraveling a complex relationship.Inhibition of retinoic acid receptor β signaling confers glycolytic dependence and sensitization to dichloroacetate in melanoma cells.Melanoma treatment in review.
P2860
Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Overexpression of pyruvate deh ...... or cutaneous melanoma therapy.
@en
type
label
Overexpression of pyruvate deh ...... or cutaneous melanoma therapy.
@en
prefLabel
Overexpression of pyruvate deh ...... or cutaneous melanoma therapy.
@en
P2860
P50
P1476
Overexpression of pyruvate deh ...... for cutaneous melanoma therapy
@en
P2093
Joana Pardal
Regina Caldas
P2860
P304
P356
10.1517/14728222.2015.1045416
P407
P577
2015-06-01T00:00:00Z